-+ 0.00%
-+ 0.00%
-+ 0.00%

Citigroup Maintains Neutral on RXO, Lowers Price Target to $15

Benzinga·04/08/2025 20:51:11
Listen to the news
Citigroup analyst Ariel Rosa maintains RXO (NYSE:RXO) with a Neutral and lowers the price target from $23 to $15.